La cadena de opciones muestra datos clave de las opciones de acciones de Evaxion Biotech a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Evaxion Biotech..

Evaxion Biotech (NASDAQ:EVAX) Bolsa, Cadena de Opciones

Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are: EVX-01, EVX-03, and EVX-02, which are vaccine candidates being developed for the treatment of various solid cancers. In addition, the company is developing EVX-B1, EVX-B2, EVX-B3, EVX-V1, and multiple other vaccine candidates for various infectious diseases, such as cytomegalovirus, N.gonorrhoeae, bacterial pathogens, and others.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ACTG

ALUR

BTAI

CNTA

DALN

DWTX

EVAX

FFBC

HYZN

LITM

MLYS

NVNI

PBBK

SEPN

STBX

TRUG

TWLO

Twilio sube un 18,5% tras superar expectativas de ingresos. Explora los movimientos clave del mercado previo de hoy.

Acciones de Twilio (TWLO) se disparan más de un 18%; 20 acciones que se mueven en el premercado de EE.UU.

IDAI

INTZ

LIDR

LKCO

LUXH

MGIH

MLGO

MRBK

MTRX

NEUP

ONDS

QRHC

RVSN

SLDP

VIRX

WTBA

Descubre las acciones que lideran los movimientos en la apertura del mercado, incluyendo repuntes destacados y caídas sorprendentes.

Acciones de Evaxion Biotech (EVAX) suben alrededor del 62%; 20 acciones que se mueven en el premercado

Long Ideas

AREN

CSTM

GDYN

GEAR

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este viernes: CSTM, VIRX, EVAX, AREN y GDYN.

5 acciones en el foco este viernes: CSTM, VIRX, EVAX, AREN y GDYN

Evaxion Biotech A/S - American Depositary Share

Evaxion Biotech AS

On April 28, 2025, Medicus Pharma Ltd. (the "Company") issued a press release announcing that the Company entered into a binding letter of intent, dated April 26, 2025 (the "Letter Agreement"), pursuant to which the Company has agreed to acquire all of the issued and outstanding shares of Antev Ltd. ("Antev") on a share exchange basis (the "Transaction"). Antev is a clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as first in market product for cardiovascular high-risk prostate cancer patients and patients with first acute urinary retention (AURr) episodes due to enlarged prostate. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Subject to certain assumptions, qualifications and conditions, the Company will negotiate and enter into a definitive agreement with Antev to acquire all issued and outstanding Antev shares, on a fully-diluted basis, in exchange for 2,666,600 common shares of the Company ("Consideration Shares"), representing approximately 19% of the issued and outstanding common shares of the Company as of the date of the Letter Agreement. In addition to resale restrictions prescribed under applicable securities laws, the Consideration Shares will be subject to a 9-month staggered lock-up release and an agreement granting certain voting rights in favor of Company management for a period of 36 months.
Upon the achievement of certain milestones related to potential future U.S. Food and Drug Administration ("FDA") Phase 2 and New Drug Administration approvals, Antev shareholders will be entitled to receive up to approximately US$65 million in additional contingent consideration.

MDCX

Medicus Pharma To Acquire Antev Ltd. For 19% Equity Stake, Or ~2.67M Shares, With Potential $65M In Milestone Payments For Prostate Drug Teverelix

Barclays analyst Brandon Oglenski maintains Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) with a Overweight and lowers the price target from $475 to $290.

Price Target

Analyst Ratings

SAIA

Barclays Maintains Overweight on Saia, Lowers Price Target to $290

Susquehanna analyst Charles Minervino maintains Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Positive and lowers the price target from $48 to $46.

Susquehanna Maintains Positive on Schlumberger, Lowers Price Target to $46

Avantor Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) reported in-line earnings for its <a href="https://www.benzinga.com/quote/AVTR/earnings">first quarter on Friday</a>.
The company posted adjusted EPS of 23 cents in line with consensus. The life science tools company reported sales of $1.58 billion, missing the consensus of $1.61 billion.
"While earnings and margin performance were in line with our plan, Lab Solutions revenue was impacted by reduced demand – particularly in our Education and Government end market – following recent policy changes," said Michael Stubblefield, president and CEO. "We are updating our full-year outlook to reflect ongoing funding and policy-related headwinds. While we are not satisfied with our current growth trajectory, we are implementing a comprehensive strategy to strengthen our Lab Solutions segment and are committed to moving with urgency to improve performance across the business."
On Friday, Avantor announced that Stubblefield intends to step down as director, president, and CEO. The Board has initiated a search process to identify the company's next CEO.
Avantor shares fell 16.6% to close at $12.93 on Friday.
These analysts made changes to their price targets on Avantor following earnings announcement.
<ul>
<li>Baird analyst Catherine Schulte maintained Avantor with an Outperform and lowered the price target from $21 to $17.</li>
<li>Morgan Stanley analyst Tejas Savant downgraded the stock from Overweight to Equal-Weight and lowered the price target from $25 to $15.</li>
<li>Barclays analyst Luke Sergott maintained Avantor with an Overweight rating and lowered the price target from $18 to $15.</li>
</ul>
Considering buying AVTR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="562" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28092545/image-197-1024x562.png" alt="" class="wp-image-890981" style="width:600px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28092545/image-197-1024x562.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28092545/image-197-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28092545/image-197-768x421.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28092545/image-197.png 1136w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/45035424/top-3-health-care-stocks-that-may-rocket-higher-in-april">Top 3 Health Care Stocks That May Rocket Higher In April</a> </li>
</ul>
Photo via Shutterstock

Earnings

AVTR

Avantor Analysts Cut Their Forecasts After Q1 Results

Barclays analyst Lauren Lieberman maintains PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) with a Equal-Weight and lowers the price target from $143 to $135.

Barclays Maintains Equal-Weight on PepsiCo, Lowers Price Target to $135

Susquehanna analyst Joseph Stauff initiates coverage on TKO Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>) with a Positive rating and announces Price Target of $180.

Initiation

Susquehanna Initiates Coverage On TKO Group Holdings with Positive Rating, Announces Price Target of $180

Barclays analyst Seth Sigman maintains O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) with a Equal-Weight and raises the price target from $1250 to $1290.

ORLY

Barclays Maintains Equal-Weight on O'Reilly Automotive, Raises Price Target to $1290

Wedbush analyst Alicia Reese maintains Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Outperform and lowers the price target from $125 to $100.

ROKU

Wedbush Maintains Outperform on Roku, Lowers Price Target to $100

Barclays analyst Lauren Lieberman maintains Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) with a Overweight and raises the price target from $37 to $38.

Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

Q4 and 2024 Year-End Preliminary Unaudited Select Financial Results
<ul>
<li>Expected $72.3 million in cash &amp; cash equivalents and short-term investments as of December 31, 2024 (inclusive of a $18 million credit facility) compared to $85.6 million in cash &amp; cash equivalents and short-term investments as of December 31, 2023 (inclusive of a $15 million credit facility).</li>
<li>Expected U.S. Generally Accepted Accounting Principles (GAAP) net loss in 2024 of $111.8 million, or $7.01 loss per share, compared to $114.2 million, $11.32 loss per share, in 2023.</li>
<li>Expected fourth quarter 2024 GAAP net loss of $37.3 million, or $1.51 loss per share, compared to $38.5 million, or $2.56 loss per share, in Q3 2024 and $35.2 million, or $3.44 loss per share, in Q4 2023. &nbsp;</li>
</ul>
The preliminary results presented reflect the Company's estimates based solely upon information available, and the Company's final results could differ from these estimates due to the completion of the Company's financial closing procedures, final adjustments and other developments that may arise between now and the time such audited consolidated financial statements for the year ended December 31, 2024 are issued. The Company expects to release the fully audited 2024 financial statements on or before May 15, 2025.

Guidance

REE Automotive Provides 2024 Business Update; Reschedules The Release Date Of Its Q4 And FY24 Financial Results To Before The Market Opens On Thursday, May 15, 2025; Sees Q4 EPS $(1.51) Up From $(3.44) YoY

Barclays analyst David Anderson maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Overweight and lowers the price target from $265 to $230.

Barclays Maintains Overweight on Fiserv, Lowers Price Target to $230

Wedbush analyst Robert Driscoll reiterates Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Outperform and maintains $67 price target.

Reiteration

RVMD

Wedbush Reiterates Outperform on Revolution Medicines, Maintains $67 Price Target

Barclays analyst Michael Leithead maintains Element Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) with a Overweight and lowers the price target from $30 to $27.

Barclays Maintains Overweight on Element Solutions, Lowers Price Target to $27

Susquehanna analyst Joseph Stauff initiates coverage on Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) with a Positive rating and announces Price Target of $37.

SPHR

Susquehanna Initiates Coverage On Sphere Entertainment with Positive Rating, Announces Price Target of $37

A widespread power outage struck large parts of Spain and Portugal on Monday, disrupting daily life and causing travel chaos. Major cities including Madrid, Barcelona, Lisbon and Seville were affected, with reports of outages also emerging from parts <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45034627/us-stock-futures-fall-as-markets-brace-for-earnings-from-microsoft-meta-apple-and-apple-this-week-earnings-estimates-dont-signal-a-recession-says-leading-analyst">of France and Andorra.&nbsp;</a>
The Details: The blackout shut down traffic lights, caused heavy congestion on roads, and halted operations at airports, train stations, and metro systems. 
Read Next: <a href="https://www.benzinga.com/25/04/45012792/trump-administration-to-resume-collections-on-student-loans-5-million-borrowers-in-default?utm_source=articleShare">Trump Administration To Resume Collections On Student Loans: 5 Million Borrowers In Default&nbsp;</a>
In Madrid, traffic reached a standstill after signals failed, prompting police to advise people to avoid unnecessary travel and drive cautiously. The Madrid Open tennis tournament was suspended and fans exited in the dark. At Lisbon's Humberto Delgado Airport, travelers waited in unlit terminals without air conditioning or running water, and shops only accepted cash.
Spain's national rail operator, Renfe, reported that the blackout stopped trains nationwide and led to canceled departures. Metro systems in Madrid, Barcelona, and Valencia were also evacuated or shut down.
Portugal's grid operator, Redes Energéticas Nacionais, confirmed that the entire Iberian Peninsula lost electrical supply and some regions in France were also impacted. E-Redes, which manages electricity distribution in Portugal, described the incident as part of a broader European problem and began restoring connections in phases.
Spanish grid operator Red Electrica said it was working closely with energy companies to restore power. It stressed that the cause was under investigation and that all resources were being dedicated to resolving the issue. 
Early reports suggest the outage may have originated from a failure in a high-voltage interconnector in France, possibly linked to a fire that damaged a crucial power line. This disconnected the Iberian Peninsula from the European grid and triggered cascading failures. However, investigations are ongoing, and officials have not ruled out other causes, including cyberattacks.
Power restoration is underway, but authorities warn it may take hours or longer. That&#8217;s due to the complexity of restarting the grid after such a large-scale blackout. 
Markets React: European markets traded higher on Monday, with all sectors in positive territory despite the power outages. The Vanguard FTSE European ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGK#NYSE">VGK</a>) was up 0.08% in premarket trading in New York. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44952117/apple-and-meta-fined-nearly-800-million-for-violating-european-unions-digital-markets-act?utm_source=articleShare">Apple And Meta Fined Nearly $800 Million For Violating European Union&#8217;s Digital Markets Act</a>&nbsp;</li>
</ul>
Photo: Shutterstock

Specialty ETFs

Eurozone

Global

ETFs

Massive Power Outages Hit Spain, Portugal Snarling Travel: Investigations Into Cause Underway

Barclays analyst Kannan Venkateshwar maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Equal-Weight and lowers the price target from $37 to $35.

CMCSA

Barclays Maintains Equal-Weight on Comcast, Lowers Price Target to $35

<a href="https://www.autonews.com/canada/anc-tesla-canada-pricing-increase-over-tariffs/">https://www.autonews.com/canada/anc-tesla-canada-pricing-increase-over-tariffs/</a>
<a href="https://autonews.com/tesla">Tesla</a> is raising prices in Canada and encouraging buyers to snap up cars that were imported before counter-tariffs were imposed on U.S.-made vehicles.

Macro Economic Events

Politics

Economics

General

TSLA

'Tesla Hikes Canadian Prices And Pushes Its Pre-Tariff Inventory' - Automotive News

Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) announced Monday it has signed a deal for a secured debt facility and has achieved key operational and financial milestones that support its path toward profitability and <a href="https://www.benzinga.com/pressreleases/25/04/g45035933/plug-power-signs-525-million-secured-credit-facility-with-yorkville-advisors-and-reports-strong-pr" target="_blank" rel="noreferrer noopener">long-term growth</a>. The stock price gained after the update.
Plug has inked a deal for a secured debt facility with Yorkville Advisors that will allow the issuance of up to $525 million of secured debentures.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/44902049/plug-power-stock-sinks-40-in-april-amid-financial-struggles-despite-hydrogen-plant-launch" rel="noreferrer noopener">Plug Power Stock Sinks 40% In April Amid Financial Struggles Despite Hydrogen Plant Launch</a>
The facility includes an initial $210 million tranche, which will be fully funded at the initial closing, as well as additional tranches of up to $315 million. The initial tranche will likely close by May 2, 2025.
With the net proceeds from the initial tranche, Plug intends to use approximately $82.5 million to retire the majority of its existing convertible debenture principal outstanding with Yorkville.
Plug will report its first-quarter 2025 results in early May. Plug expects to report revenue of approximately $130 million to $134 million for the first quarter of 2025, compared to the analyst consensus of $131.61 million. Plug expects second-quarter revenue of $140 million to $180 million, versus the analyst consensus of $160.20 million.
Plug expects first-quarter net cash usage of approximately $142 million compared to $268 million a year ago. The company ended March 31, 2025, with approximately $296 million in unrestricted cash.
Plug completed construction of its new 15 TPD hydrogen production plant in St. Gabriel, Louisiana. Operated through the Hidrogenii joint venture with Olin Corporation, this facility strengthens Plug&#8217;s vertically integrated hydrogen network and will serve anchor customers, including Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>).
Plug has taken decisive actions to reduce its operational cost base, implementing changes in the first quarter that will likely drive over $200 million in incremental annualized run-rate savings. These cost-cutting measures, which have been largely completed, include organizational realignment and a company-wide focus on manufacturing and supply chain efficiency. The full impact of these cost savings will begin to be reflected in the coming quarters.
Plug Power stock has plunged over 65% year-to-date <a href="https://www.benzinga.com/quote/PLUG/analyst-ratings" target="_blank" rel="noreferrer noopener">after analysts cut</a> their price targets for the stock, as it failed to meet its quarterly revenue and EPS consensus.
Price Action: PLUG stock is up 12.0% at $0.9056 premarket at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44757588/lucid-wins-nikola-bankruptcy-auction-buys-nikola-facilities-for-30-million-to-boost-us-ev-production" target="_blank" rel="noreferrer noopener">Lucid Wins Nikola Bankruptcy Auction, Buys Nikola Facilities for $30 Million To Boost US EV Production</a></li>
</ul>
Photo: Shutterstock

AMZN

PLUG

Plug Power Rallies As New Financing, Cost Cuts Boost Confidence In Turnaround Plan

Government

Legal

STLA

Watching Shares Of Domestic Automakers; Reuters Reports Letter Sent By Major Automakers Urging Congress To Block California's Plan To End Sales Of Gas-Only Vehicles By 2035

Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) shares got a slight bump in early trading Monday. The company announced the termination of a 2018 consent order from the <a href="https://www.benzinga.com/pressreleases/25/04/b45036401/wells-fargo-confirms-termination-of-2018-cfpb-compliance-consent-order">Consumer Financial Protection Bureau (CFPB)</a>.
What Happened: Wells Fargo on Monday confirmed that the CFPB&#8217;s consent order related to the company&#8217;s risk management program has been terminated, representing the twelfth consent order closed by Wells Fargo regulators since 2019. 
&#8220;Today&#8217;s termination, along with the recent closure of other consent orders, demonstrates that we have completed much of our common risk and control infrastructure work, including work that is required by other orders,&#8221; said Charlie Scharf, CEO of Wells Fargo.
&#8220;I am proud of the work done by our teams and remain confident that we will complete the work needed to close our other open consent orders. Wells Fargo is a different and stronger company today as we focus on creating long-term value for our customers, clients, communities and shareholders.&#8221;
See Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45035728/5-stocks-in-the-spotlight-last-week-wall-streets-most-accurate-analysts-weigh-in">5 Stocks In The Spotlight Last Week: Wall Street&#8217;s Most Accurate Analysts Weigh In</a>
<h3 class="wp-block-heading">How To Buy WFC Stock</h3>
By now you're likely curious about how to participate in the market for Wells Fargo &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Wells Fargo, which is trading at $69.73 as of publishing time, $100 would buy you 1.43 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
WFC Price Action: <a href="http://benzinga.com/quote/WFC">Wells Fargo shares</a> were up 0.32% at $69.95 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Bumble Dee/Shutterstock.

What's Going On With Wells Fargo Stock Today?

Press Releases

Evaxion announces closing of $10.8 million public offering

Peraso Inc. (NASDAQ: PRSO) Rides Military AI Boom as Defense Spending Surges – More Stocks Inside

Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination

Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package

Evaxion to present at numerous upcoming conferences

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Evaxion to announce business update and full year 2024 financial results on April 1, 2025

Evaxion announces business update and full year 2024 financial results

Evaxion to present at World Vaccine Congress

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

Comments

Evaxion Biotech

Evaxion Biotech (EVAX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL